Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Lapatinib | 0.1 | uM | 7 | 156.25 | 28.40 | 96.00 | 117.00 | 0.8205 | 0.8154 |
| BT-20 | 17-AAG | 0.31623 | uM | 7 | 156.25 | 28.40 | 73.00 | 117.00 | 0.6239 | 0.5876 |
| BT-20 | Linsitinib | 10 | uM | 7 | 156.25 | 28.40 | 108.00 | 117.00 | 0.9231 | 0.9232 |
| BT-20 | Linsitinib | 0.31623 | uM | 7 | 156.25 | 28.40 | 116.00 | 117.00 | 0.9915 | 0.9916 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 156.25 | 28.40 | 139.00 | 117.00 | 1.1880 | 1.1760 |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 156.25 | 28.40 | 117.00 | 117.00 | 1.0000 | 1.0000 |
| BT-20 | Erlotinib | 1 | uM | 7 | 156.25 | 28.40 | 109.00 | 117.00 | 0.9316 | 0.9318 |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 112.00 | 117.00 | 0.9573 | 0.9577 | |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 3.00 | 117.00 | 0.0256 | -0.6672 | |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 2.00 | 117.00 | 0.0171 | -0.7271 | |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 84.00 | 117.00 | 0.7180 | 0.7005 | |
| BT-20 | Linsitinib | 3.1623 | uM | 7 | 156.25 | 28.40 | 106.00 | 117.00 | 0.9060 | 0.9056 |
| BT-20 | Linsitinib | 0.01 | uM | 7 | 156.25 | 28.40 | 112.00 | 117.00 | 0.9573 | 0.9577 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 156.25 | 28.40 | 114.00 | 117.00 | 0.9744 | 0.9747 |
| BT-20 | 17-AAG | 0.0016596 | uM | 7 | 156.25 | 28.40 | 61.00 | 117.00 | 0.5214 | 0.4540 |
| BT-20 | 17-AAG | 1 | uM | 7 | 156.25 | 28.40 | 62.00 | 117.00 | 0.5299 | 0.4656 |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 156.25 | 28.40 | 110.00 | 117.00 | 0.9402 | 0.9405 |
| BT-20 | 17-AAG | 0.031623 | uM | 7 | 156.25 | 28.40 | 69.00 | 117.00 | 0.5897 | 0.5444 |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 106.00 | 117.00 | 0.9060 | 0.9056 | |
| BT-20 | Lapatinib | 3.1623 | uM | 7 | 156.25 | 28.40 | 90.00 | 117.00 | 0.7692 | 0.7589 |
| BT-20 | 17-AAG | 0.01 | uM | 7 | 156.25 | 28.40 | 62.00 | 117.00 | 0.5299 | 0.4656 |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 130.00 | 117.00 | 1.1111 | 1.1059 | |
| BT-20 | Erlotinib | 10 | uM | 7 | 156.25 | 28.40 | 125.00 | 117.00 | 1.0684 | 1.0658 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 156.25 | 28.40 | 131.00 | 117.00 | 1.1197 | 1.1138 |
| BT-20 | Lapatinib | 10 | uM | 7 | 156.25 | 28.40 | 48.00 | 117.00 | 0.4103 | 0.2930 |